Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 2.14 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 7:40 AM 03/16/15 All times are local (Market data is delayed by at least 15 minutes).

kdl biotech ltd (KOPD) Snapshot

Open
--
Previous Close
2.14
Day High
--
Day Low
--
52 Week High
03/9/15 - 2.25
52 Week Low
12/22/14 - 1.62
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
-6.74
Shares Outstanding
24.0M
EX-Date
09/25/06
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KDL BIOTECH LTD (KOPD)

Related News

No related news articles were found.

kdl biotech ltd (KOPD) Related Businessweek News

No Related Businessweek News Found

kdl biotech ltd (KOPD) Details

KDL Biotech Limited engages in the manufacture and sale of pharmaceutical products primarily in India. The company is based in Khopoli, India.

kdl biotech ltd (KOPD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kdl biotech ltd (KOPD) Key Developments

KDL Biotech Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2013

KDL Biotech Limited announced unaudited standalone earnings results for the first quarter ended June 30, 2013. For the quarter, the standalone company reported net sales of INR 3.490 million against INR 16.841 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 29.558 million against INR 31.244 million a year ago. Loss from ordinary activities before tax was INR 46.005 million against INR 47.287 million a year ago. Net loss was INR 46.005 million against INR 47.287 million a year ago. Basic and diluted loss per share before and after extraordinary items were INR 1.91 against INR 1.97 a year ago.

KDL Biotech Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

KDL Biotech Limited announced unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the standalone company reported net sales of nil against INR 3.490 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 20.277 million against INR 29.558 million a year ago. Loss from ordinary activities before tax was INR 32.090 million against INR 46.005 million a year ago. Net loss was INR 32.090 million against INR 46.005 million a year ago. Basic and diluted loss per share before and after extraordinary items were INR 1.34 against INR 1.91 a year ago.

KDL Biotech Limited Announces Unaudited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2014

KDL Biotech Limited announced unaudited standalone earnings results for the fourth quarter and full year ended March 31, 2014. For the quarter, the standalone company reported net sales of nil against INR 16.123 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 28.739 million against INR 19.989 million a year ago. Loss from ordinary activities before tax was INR 44.327 million against INR 36.055 million a year ago. Net loss was INR 44.327 million against INR 36.055 million a year ago. Diluted loss per share before and after extraordinary items were INR 1.84 and INR 1.81, respectively against INR 1.50 a year ago. For the full year, the standalone company reported net sales of INR 3.490 million against INR 62.425 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 104.578 million against INR 97.062 million a year ago. Loss from ordinary activities before tax was INR 169.587 million against INR 162.077 million a year ago. Net loss was INR 169.587 million against INR 162.077 million a year ago. Basic and diluted loss per share before and after extraordinary items were INR 7.06 against INR 6.74 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KOPD:IN 2.14 INR 0.00

KOPD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KOPD.
View Industry Companies
 

Industry Analysis

KOPD

Industry Average

Valuation KOPD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KDL BIOTECH LTD, please visit www.kdlbiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.